Standard BioTools Inc’s recent filing unveils that its Former Officer Black Jeffrey G. acquired Company’s shares for reported $0.12 million on Nov 12 ’24. In the deal valued at $2.12 per share,57,971 shares were bought.
Then, Taich Adam bought 45,851 shares, generating $91,725 in total proceeds.
Before that, Casdin Partners Master Fund, L bought 250,000 shares. Standard BioTools Inc shares valued at $546,750 were divested by the Director at a price of $2.19 per share. As a result of the transaction, Casdin Partners Master Fund, L now holds 54,025,821 shares, worth roughly $111.29 million.
TD Cowen initiated its Standard BioTools Inc [LAB] rating to a Buy in a research note published on April 16, 2024; the price target was $3.50. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. KeyBanc Capital Markets began covering LAB with “an Overweight” recommendation on July 12, 2023.
Price Performance Review of LAB
On Monday, Standard BioTools Inc [NASDAQ:LAB] saw its stock jump 26.38% to $2.06. Over the last five days, the stock has gained 13.19%. Standard BioTools Inc shares have risen nearly 17.71% since the year began. Nevertheless, the stocks have risen 7.29% over the past one year. While a 52-week high of $3.04 was reached on 01/13/25, a 52-week low of $1.21 was recorded on 01/10/25. SMA at 50 days reached $1.8700, while 200 days put it at $2.0800.
Levels Of Support And Resistance For LAB Stock
The 24-hour chart illustrates a support level at 1.7900, which if violated will result in even more drops to 1.5300. On the upside, there is a resistance level at 2.2300. A further resistance level may holdings at 2.4100. The Relative Strength Index (RSI) on the 14-day chart is 59.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0100, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 14.41%. Stochastics %K at 35.33% indicates the stock is a holding.
How much short interest is there in Standard BioTools Inc?
A steep rise in short interest was recorded in Standard BioTools Inc stocks on 2024-12-31, dropping by -0.24 million shares to a total of 13.52 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 13.77 million shares. There was a decline of -1.8%, which implies that there is a negative sentiment for the stock.
